Showing results (271-280 of 390) with videos related to

Sort By:
Pageof 39
Journal of the European Academy of Dermatology and Venereology : JEADV|October 8, 2009
Treatment of nail psoriasis with adalimumab: an open label unblinded studyD Rigopoulos, S Gregoriou, E Lazaridou, et al.
Nature Chemical Biology|November 16, 2018
Synthesis of 11-carbon terpenoids in yeast using protein and metabolic engineeringCodruta Ignea, Marianna Pontini, Mohammed S Motawia, et al.
British Journal of Haematology|August 1, 1994
A cross-over pharmacokinetic and thrombogenicity study of a prothrombin complex concentrate and a purified factor IX concentrateD P Thomas, K K Hampton, H Dasani, et al.
Transfusion|March 1, 1995
Low risk of viral infection after administration of vapor-heated factor VII concentrate or factor IX complex in first-time recipients of blood components. International Factor Safety Study GroupA Shapiro, T Abe, L M Aledort, et al.
British Journal of Haematology|January 1, 1989
Antithrombin Sheffield: amino acid substitution at the reactive site (Arg393 to His) causing thrombosisD A Lane, H Erdjument, A Flynn, et al.
International Journal of Laboratory Hematology|January 15, 2008
The effect of tissue factor concentration on calibrated automated thrombography in the presence of inhibitor bypass agentsJ J van Veen, A Gatt, A E Bowyer, et al.
International Journal of Immunopathology and Pharmacology|September 17, 2005
Theophylline as "add-on" therapy in patients with delayed pressure urticaria: a prospective self-controlled studyD Kalogeromitros, D Kempuraj, A Katsarou-Katsari, et al.
Infection and Immunity|November 1, 1991
In vitro binding of Helicobacter pylori to human gastric mucinL S Tzouvelekis, A F Mentis, A M Makris, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2009
In vitro trafficking and efficacy of core-shell nanostructures for treating intracellular Salmonella infectionsA Ranjan, N Pothayee, M N Seleem, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1985
The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after traumaC Kluft, J H Verheijen, A F Jie, et al.
Pageof 39